Canine Interleukin-31 Monoclonal Antibody
123 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
123
Total Reports
10
Deaths Reported
810.0%
Death Rate
Active Ingredients
Canine Interleukin-31 Monoclonal Antibody
Administration Routes
UnknownParenteralSubcutaneousOther
Species Affected
Dog 123
Most Affected Breeds
Retriever - Golden 10
Bulldog - French 8
Shepherd Dog - German 8
Maltese 7
Retriever - Labrador 7
Shih Tzu 7
Crossbred Canine/dog 6
Pit Bull 6
Terrier - Yorkshire 5
Dog (unknown) 5
Most Reported Reactions
Vomiting 21
Diarrhoea 19
Lethargy (see also Central nervous system depression in Neurological) 17
Lack of efficacy - NOS 16
Not eating 13
Behavioural disorder NOS 11
Allergy NOS 11
Weight loss 10
Elevated alanine aminotransferase (ALT) 9
Elevated blood urea nitrogen (BUN) 8
Other abnormal test result NOS 8
Panting 8
Outcome Breakdown
Outcome Unknown
45 (36.6%)
Ongoing
45 (36.6%)
Recovered/Normal
23 (18.7%)
Euthanized
8 (6.5%)
Died
2 (1.6%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.